WallStreetZenWallStreetZen

NYSE: WST
West Pharmaceutical Services Inc Stock

$322.07-14.01 (-4.17%)
Updated Jun 18, 2024
WST Price
$322.07
Fair Value Price
N/A
Market Cap
$23.46B
52 Week Low
$310.00
52 Week High
$415.73
P/E
41.99x
P/B
8.75x
P/S
9.93x
PEG
5.33x
Dividend Yield
0.25%
Revenue
$2.93B
Earnings
$568.70M
Gross Margin
37.2%
Operating Margin
23.64%
Profit Margin
19.4%
Debt to Equity
0.34
Operating Cash Flow
$757M
Beta
0.86
Next Earnings
Jul 25, 2024
Ex-Dividend
Jul 31, 2024
Next Dividend
Aug 7, 2024

WST Overview

West Pharmaceutical Services Incorporated manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the U.S. and internationally. Its Proprietary Products segment offers stoppers and seals for injectable packaging systems, and syringe and cartridge components for injectable drug applications. The Contract-Manufactured Products segment manufactures and (automated) assembles devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical and medical device companies. The company was incorporated in 1923 and is headquartered in Exton, PA.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how WST scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

WST ($322.07) is trading above its intrinsic value of $63.23, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
WST is poor value based on its earnings relative to its share price (41.99x), compared to the US market average (31.44x)
P/E vs Market Valuation
WST is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more WST due diligence checks available for Premium users.

Be the first to know about important WST news, forecast changes, insider trades & much more!

WST News

Valuation

WST price to earnings (PE)

For valuing profitable companies with steady earnings
Company
41.99x
Industry
55.68x
Market
31.44x
WST is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
WST is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

WST price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.75x
Industry
3.64x
WST is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

WST price to earnings growth (PEG)

For valuing profitable companies with growth potential
WST is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

WST's financial health

Profit margin

Revenue
$695.4M
Net Income
$115.3M
Profit Margin
16.6%
WST's Earnings (EBIT) of $692.20M... subscribe to Premium to read more.
Interest Coverage Financials
WST's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$3.6B
Liabilities
$921.7M
Debt to equity
0.34
WST's short-term assets ($1.69B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WST's short-term assets ($1.69B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WST's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
WST's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$118.2M
Investing
-$90.6M
Financing
-$271.0M
WST's operating cash flow ($756.60M)... subscribe to Premium to read more.
Debt Coverage Financials

WST vs Medical Stocks

TickerMarket Cap1d %P/EP/B
WST$23.46B-4.17%41.99x8.75x
COO$18.25B-0.87%53.45x2.34x
BAX$17.19B-0.53%6.45x2.10x
HOLX$16.68B+0.06%36.46x3.44x
RMD$31.18B+0.91%32.56x6.74x

West Pharmaceutical Services Stock FAQ

What is West Pharmaceutical Services's quote symbol?

(NYSE: WST) West Pharmaceutical Services trades on the NYSE under the ticker symbol WST. West Pharmaceutical Services stock quotes can also be displayed as NYSE: WST.

If you're new to stock investing, here's how to buy West Pharmaceutical Services stock.

What is the 52 week high and low for West Pharmaceutical Services (NYSE: WST)?

(NYSE: WST) West Pharmaceutical Services's 52-week high was $415.73, and its 52-week low was $310.00. It is currently -22.53% from its 52-week high and 3.89% from its 52-week low.

How much is West Pharmaceutical Services stock worth today?

(NYSE: WST) West Pharmaceutical Services currently has 72,843,157 outstanding shares. With West Pharmaceutical Services stock trading at $322.07 per share, the total value of West Pharmaceutical Services stock (market capitalization) is $23.46B.

West Pharmaceutical Services stock was originally listed at a price of $7.44 in Dec 31, 1997. If you had invested in West Pharmaceutical Services stock at $7.44, your return over the last 26 years would have been 4,230.06%, for an annualized return of 15.6% (not including any dividends or dividend reinvestments).

How much is West Pharmaceutical Services's stock price per share?

(NYSE: WST) West Pharmaceutical Services stock price per share is $322.07 today (as of Jun 18, 2024).

What is West Pharmaceutical Services's Market Cap?

(NYSE: WST) West Pharmaceutical Services's market cap is $23.46B, as of Jun 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

West Pharmaceutical Services's market cap is calculated by multiplying WST's current stock price of $322.07 by WST's total outstanding shares of 72,843,157.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.